This double blinded randomized controlled trial aims to assess the efficacy of a novel oral synbiotic formula (SMT04) in reducing adenoma recurrence and colorectal neoplasia-related bacterial gene mar

NIAID Data Ecosystem60

MOESM4 of The use of PanDrugs to prioritize anticancer drug treatments in a case of T-ALL based on individual genomic data

个体化癌症治疗

基因组药物反应预测

Additional file 4: Table S4. Results of crossing exome and transcriptome data.

NIAID Data Ecosystem30

Supplementary Table 2 from Polymorphisms in Cyclooxygenase , Lipoxygenase , and TP53 Genes Predict Colorectal Polyp Risk Reduction by Aspirin in the seAFOod Polyp Prevention Trial

药物基因组学

结直肠癌预防

Supplementary Table 2 shows the results of Negative binomial regression analysis of total colorectal polyp number according to aspirin use stratified for each SNP

NIAID Data Ecosystem10

Table 1 from Polymorphisms in <i>Cyclooxygenase</i>, <i>Lipoxygenase</i>, and <i>TP53</i> Genes Predict Colorectal Polyp Risk Reduction by Aspirin in the seAFOod Polyp Prevention Trial

资源简介：

Table 1 from Polymorphisms in <i>Cyclooxygenase</i>, <i>Lipoxygenase</i>, and <i>TP53</i> Genes Predict Colorectal Polyp Risk Reduction by Aspirin in the seAFOod Polyp Prevention Trial

资源简介：

相关数据集